Hi,

 

I’m following up on my prior email. We contributed an early version of our fetal cerebellum data to the covid10cellatlas (Aldinger et al). I would like to update with our finalized dataset. Our revised manuscript detailing the methods and analysis of our data has been submitted for revision.

 

I look forward to hearing from you.

 

Cheers,

Kim

 

Kimberly A Aldinger, PhD (she/her)

 

Center for Integrative Brain Research (CIBR)

Seattle Children's Research Institute

Member, Brotman Baty Institute for Precision Medicine

 

206-884-1226  OFFICE

206-884-1210  FAX

 

OFFICE   Center for Integrative Brain Research, Seattle Children's Research Institute, 1900 9th Avenue, Seattle, WA 98101    

MAIL      1900 9th Avenue, M/S JMB-10, Seattle, WA 98101

WWW      https://www.seattlechildrens.org/directory/kimberly-aldinger/ [seattlechildrens.org]

 

 

 

 

From: "Aldinger, Kimberly" <Kimberly.Aldinger@seattlechildrens.org>
Date: Saturday, February 20, 2021 at 2:47 PM
To: "cv19caingest@sanger.ac.uk" <cv19caingest@sanger.ac.uk>
Subject: updated dataset for COVID-19 Cell Atlas

 

Hi,


I previously contributed data to the COVID-19 Cell Atlas. I now have an updated/finalized Fetal Cerebellum dataset that I would like to replace for the dataset that is currently hosted: https://www.covid19cellatlas.org/index.healthy.html

 

What is the best way to transfer the updated .rds?

 

Thanks!


Kimberly A Aldinger, PhD (she/her)

 

Center for Integrative Brain Research (CIBR)

Seattle Children's Research Institute

Member, Brotman Baty Institute for Precision Medicine

 

206-884-1226  OFFICE

206-884-1210  FAX

 

OFFICE   Center for Integrative Brain Research, Seattle Children's Research Institute, 1900 9th Avenue, Seattle, WA 98101    

MAIL      1900 9th Avenue, M/S JMB-10, Seattle, WA 98101

WWW      https://www.seattlechildrens.org/directory/kimberly-aldinger/ [seattlechildrens.org]

 

 

CONFIDENTIALITY NOTICE: This e-mail, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information protected by law. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.